A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer

Sagar Sardesai, Mohamed Badawi, Ewa Mrózek, Evan Morgan, Mitch A. Phelps, Julie Stephens, Lai Wei, Mahmoud Kassem, Yonghua Ling, Maryam B. Lustberg, Daniel G. Stover, Nicole Williams, Rachel M. Layman, Raquel E. Reinbolt, Jeffrey VanDeusen, Mathew Cherian, Michael R. Grever, William E. Carson, Bhuvaneswari Ramaswamy, Robert Wesolowski